MEPSGEN to Showcase Next-Generation MPS and DDS Platforms at BIO USA
2026-06-15
MEPSGEN Partners with Imperial College London to Co-Develop IBD Model
2026-05-29
MEPSGEN Highlights Its Automated MPS Modeling System at MPS World Summit 2026
2026-05-22
HLB Pharmaceutical Joins Hands with MEPSGEN to Strengthen Competitiveness in Next-Generation Drug Delivery Technologies
2026-04-28
MEPSGEN Accelerates Large-Scale Microparticle Production for Long-Acting Injectable Formulations
2026-04-27
MEPSGEN Selected as a ‘2026 Global IP Star Company’ by the Korean Intellectual Property Office (KIPO)
2026-04-21
MEPSGEN partners with Imperial College London’s newly established 'Centre for Intestinal Systems'
2026-01-16
MEPSGEN Awarded the Presidential Citation at the 2025 Venture Entrepreneurship Awards
2025-12-11
MEPSGEN partners with Sungkyunkwan University to develop glioblastoma tumor microenvironment model
2025-11-04
FDA’s Animal Testing Reform Paves the Way for MEPSGEN’s Next-Generation Organ-on-a-Chip Technology
2025-10-28
MEPSGEN and Chung-Ang University research team collaborate on joint development for stroke drug screening.
2025-10-15
MEPSGEN and Korea University Professor Chung's team agree to co-develop kidney models
2025-09-03
[Expert Column] Lab-on-a-Chip: Driving a New Revolution in Biotechnology
2025-08-19
MEPSGEN Selected for MOTIE Project on "Development of Multi-Organ Chips for Non-Clinical Drug Evaluation
2025-08-08
MEPSGEN Successfully Hosts the 2025 MEPS-X Workshop
2025-07-22
MEPSGEN Signs Research Agreement with Inha University for Joint Development of Placenta Model
2025-07-08
MEPSGEN and Karis Bio Sign MOU to Co-Develop Advanced Cardiovascular Tissue Models
2025-06-30
MEPSGEN Joins BIO USA 2025 to Expand Global Partnerships
2025-06-10
MEPSGEN partners with Cleveland Clinic to advance human gut-on-a-chip research
2025-05-28
Introducing the Next Generation of MPS Technology by MEPSGEN
2025-05-22
